Biotop-report 2014

With more than 15 years of experience, Portus 

 

Corporate Finance supports technology focused 

 

companies in all areas of financing. We base our work 

on  solid  know-how, years  of experience  and  reliable 

business partners. 

If you are looking  for  advise  and  support  in  the  

areas of

• Company and Project Funding

• Company Succession / M&A

• Finance Management / CFO-Services 

• Consulting and Coaching

• Establishment of Businesses

please don‘t hesitate to contact us!

Corporate Finance Consulting for Life Science Companies

www.PortusCo.com

Portus Corporate Finance GmbH

Friedrichstr. 81

D-10117 Berlin

Tel 

[phone] 900

Fax 

[phone] 901

Email  [e-mail] 

We have offices in Berlin/Bremen/Cologne/Frankfurt/Hamburg/Munich/Stuttgart

For further information please contact Dr. Ulla Peters

UHY Deutschland AG · Wirtschaftsprüfungsgesellschaft · Zimmerstraße 23 · 10969 Berlin

Phone [phone] · Fax [phone] · www.uhy-deutschland.de · www.uhy.com

UHY Deutschland AG is a joint venture of long established 

auditing and consulting firms with a total of 250 employees 

and partners. 

As a member of UHY International, a global association of 

independent  accounting  and  consulting  firms  with  over 

7,600  employees,  we  can  provide  audit,  accounting,  tax 

and consulting services in 275 business centres across the 

globe.

UHY Deutschland AG has extensive experience in financial 

and  consulting  services  for  life  sciences  companies  for 

many years. 

We offer the following services:

 

• Audits of financial and consolidated statements 

under the German Commercial Code (HGB) and IFRS

 

• Accounting & Reporting

 

• Due diligence (financial and tax) and business valuations

 

• Consulting services on IPOs

 

• Business Advisory

 

• Mergers & Acquisitions (M&A)

 

• German and international taxation

---

20

BioTOPics 47 | May 2014 

BioTOP-Report

 Bioelectronics  

Bioelectronics 

The Joint Lab Bioelectronics – 

A New Platform for the Integration of 

Microelectronics into Life Sciences

The introduction of  new experimental techniques causes a major advantage in the field of  biology. Well-known 

examples are the invention of  optical and electron microscopy, without which the fundamental structures of  life as 

cells and cell organelles could not have been discovered. The next paradigm shift may very well be triggered by 

applying microelectronics – and its developing field of  bioelectronics – at its interdisciplinary interface with the life 

sciences.

This positive outlook is mainly a result of  the phenomenon called 

“scaling” in microelectronics: for the last few decades, minimum 

feature dimensions have continuously become smaller by a fac-

tor of  around two every second year. At first glance, this seems 

to be a minor development relating to an uninteresting technical 

parameter, since we have become accustomed to working with 

increasingly powerful computers and to storing higher and higher 

data volumes on a single flash memory. For the life sciences, how-

ever, scaling is a major advance. It has taken microelectronics or 

more accurately, nanoelectronics, to the same structural levels at 

which the molecular mechanisms of  life operate. 

Particularly interesting perspectives arise for biosensorics, in 

which semiconductor preparation technology can be applied to 

the fabrication of  cost-effective diagnostic systems. Bioelectron-

ics is also significant for the process analytical techniques (PAT) 

for monitoring, regulating and increasing the efficiency of  biopro-

cesses. The Berlin-Brandenburg region is eager to take advan-

tage of  this development and therefore, IHP in Frankfurt (Oder) 

and the TU Berlin Institute of  Biotechnology have founded Joint 

Lab Bioelectronics. This step will intensify the interdisciplinary ex-

change between the two disciplines and expand biotechnology 

students’ knowledge of  the basics of  microelectronics.

JANUARY 2013

Charité and FU are jointly successful in the competition "EXIST-Gründungskultur 

– Die Gründerhochschule" of  the German Federal Ministry of  Economics and 

Technology 

+++ 

German Research Foundation extends collaborative research 

centre (SBF 650) at Charité – ten million Euros for research on immunological 

therapy

FEBRUARY 2013

Humboldt research award gets Ivy-League professor Klaas van Wijk to Potsdam 

+++ 

Biopolymers – strong future field with high potential for innovation presents 

itself  in Schorfheide

MARCH 2013

Hasso-Plattner-Institut speeds up personalised medicine with new data bank 

technology 

+++ 

Integrative Research Institute for Life Sciences (IRI) founded in 

Berlin 

+++ 

Paul Ehrlich- and Ludwig Darmstaedter Prize goes to MDC scientist 

Dr. James Poulet

APRIL 2013

Charité and Sorbonne found Virchow-Villermé Centre for Public Health 

+++ 

EU-

OPENSCREEN included in the new BMBF-roadmap for large research infrastruc-

tures

MAY 2013

New laboratory building of  MDC opened – named after physiologist Max Rubner 

+++ 

Stem cell researchers in Germany pool their expertise. They found the Ger-

man Stem Cell Network (GSCN) on May 7

th

 2013 

+++ 

Evaluators praise Berlin 

Institute of  Health (BIH). Enst Theodor Rietschel becomes chairman

JUNE 13

BIH officially opened 

+++ 

Charité – Universitätsmedizin Berlin once more reach-

es rank 1 of  Focus-ranking "Germany's best hospital"

JULY 2013

Prof. Angelika Eggert receives Einstein professorship and takes over as head of  

the Children's Clinic with focal areas of  oncology and hematology 

+++

 Scien-

tists from the A*STAR Genome Institute Singapore and the Max Planck Institute 

for Molecular Genetics (MPIMG) in Berlin decode the communication network in 

human embryonic stem cells 

+++

 Scientists from Charité and the MDC, working 

in cooperation with colleagues in Kiel, Boston, Zurich and London, discover a 

new gene for hereditary heart failure 

+++ 

Scientists working with Peter Seeberger 

(MPIKG) in Potsdam-Golm have developed a simple, cheap and reliable test for 

Yersinia pestis, the bacteria that caused the plague

AUGUST 2013

1000th protein structure decoded at BESSY II 

+++ 

The World Health Summit 2013 

in Berlin in August 2013 discussed solutions for global healthcare with regard to 

“Research and Innovation.” 

+++ 

BPI and vfa present national plans of  action for 

the quick diagnosis and more effective treatment of  rare diseases

SEPTEMBER 2013

Scientists at Charité and MDC discover sugar withdrawal as an innovative cancer 

therapy approach 

+++ 

Technische Universität Berlin and Leibniz Institute IHP 

Frankfurt (Oder) have established Joint Lab Bioelectronics, a laboratory for joint 

interdisciplinary research 

+++ 

Charité and Harvard sign a cooperation agree-

ment aimed at accelerating clinical translation, primarily in the cell and tissue 

technology field 

+++

 Prof. Annette Grüters-Kieslich, Charité Dean, receives the 

Prof. Dr. Peter Neubauer 

Technische Universität Berlin 

Institute for Biotechnology

Chair for Bioprocess Engineering

The Joint Lab Bioelectronics aims to advance the field of  Bio-

Process Analytical Technologies by connecting sensor spe-

cialists and bioengineers.

---